載入...
Transcriptome profiling of peripheral blood immune cell populations in multiple sclerosis patients before and during treatment with a sphingosine‐1‐phosphate receptor modulator
AIMS: Fingolimod is a sphingosine‐1‐phosphate (S1P) receptor modulator approved for the treatment of the relapsing form of multiple sclerosis (MS). It prevents the egress of lymphocyte subpopulations from lymphoid tissues into the circulation. Here, we explored the broad effects of fingolimod on gen...
Na minha lista:
| 發表在: | CNS Neurosci Ther |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6490155/ https://ncbi.nlm.nih.gov/pubmed/29314605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12793 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|